CUE Inc.
USPTO PatentsView assignee record - 18 granted patents across 14 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).
The verdict
According to USPTO PatentsView, CUE ranks #15,934 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 14 technology areas.
- #15,934
- of 49,997 US assignees by volume
- Top 50%
- by Innovation Score (35.1/100)
- 19.6
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R15934 · US Corporation #15,934 · 18 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 18 grants
- MID-PACK #15,934/49,997
- PHOTO-FINISH Calnetix
- CPC-FOCUS B01L · 14 areas
- INNOV-THIN 35.1/100
- CLAIMS-RICH 19.6 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Calnetix Technologies, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How CUE’s 35.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around CUE
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- CUE · this assignee
CUE · this assignee
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows CUE's Innovation Score is 35.1/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for CUE?
Each dot is one of CUE’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). CUE’s own 19.6 claims/patent is ABOVE the 14.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where CUE's grants concentrate
CUE Inc. is a focused PatentsView assignee: 14 CPC subclasses with 77.8% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2017 (7 grants) versus a trough of 1 in 2018. By volume, CUE sits between Crescendo Biologics Limited and Calnetix Technologies, LLC.
Who files at CUE's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Crescendo Biologi…
Crescendo Biologics Limited
18 patents
- Cryptzone North A…
Cryptzone North America, Inc.
18 patents
- CTK
CTK Co., Ltd.
18 patents
- Cubtek
Cubtek Inc.
18 patents
- Curlin Medical
Curlin Medical Inc.
18 patents
- CV6 Therapeutics…
CV6 Therapeutics (NI) Limited
18 patents
- Cyvek
Cyvek, Inc.
18 patents
- Calnetix
Calnetix Technologies, LLC
18 patents
- CUE ◀
CUE Inc.
18 patents
What this shows CUE holds 18 patents at rank #15,908, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near CUE
By rank, the assignees closest to #15,908 in granted patent volume.
- Crescendo Biologics Limited #15,904 · 18 patents
- Cryptzone North America, Inc. #15,905 · 18 patents
- CTK Co., Ltd. #15,906 · 18 patents
- Cubtek Inc. #15,907 · 18 patents
- Curlin Medical Inc. #15,909 · 18 patents
- CV6 Therapeutics (NI) Limited #15,910 · 18 patents
- Cyvek, Inc. #15,911 · 18 patents
- Calnetix Technologies, LLC #15,912 · 18 patents
Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)
Other assignees with the most granted patents in CUE's primary technology class.
- The Regents of the University of California 239 in class
- Illumina, Inc. 232 in class
- Becton, Dickinson and Company 193 in class
- Bio-Rad Laboratories, Inc. 174 in class
- President and Fellows of Harvard College 165 in class
- Life Technologies Corporation 158 in class
- Roche Diagnostics Operations, Inc. 141 in class
- Siemens Healthcare Diagnostics Inc. 119 in class
CUE's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 33.3% |
| 2016 | 4 | 22.2% |
| 2017 | 7 | 38.9% |
| 2018 | 1 | 5.6% |
Which technologies does CUE Inc. patent most?
Top 14 of 14 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
CUE Inc.'s patent record in context - here's where to go next.
- CUE Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 77.8% of its portfolio - see every assignee active in that class. Explore B01L
- Ranked #15,934 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare CUE Inc. against Crescendo Biologics Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 35.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.